Frontier Biotechnologies Revenue

In the year 2025, Frontier Biotechnologies had annual revenue of 143.67M CNY with 10.96% growth. Frontier Biotechnologies had revenue of 40.29M in the quarter ending December 31, 2025, with 6.52% growth.

Revenue

143.67M

Revenue Growth

+10.96%

P/S Ratio

53.24

Revenue / Employee

475.72K

Employees

524

Market Cap

7.65B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	143.67M	14.20M	10.96%
Dec 31, 2024	129.47M	15.22M	13.32%
Dec 31, 2023	114.25M	29.51M	34.82%
Dec 31, 2022	84.74M	44.24M	109.22%
Dec 31, 2021	40.50M	-6.12M	-13.13%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Hainan Haiyao	825.66M
HARBIN GLORIA PHARMACEUTICALS Co., LTD	2.25B
Northeast Pharmaceutical Group	6.85B
Shandong Wit Dyne Health	2.36B
Hunan Jiudian Pharmaceutical	3.05B
Jiuzhitang	1.94B
Dezhan Healthcare Company	389.51M
Cisen Pharmaceutical	3.56B

Revenue Rankings